5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2(3H)-one, 95.0%, 100mg

2-(2-Methoxyethyl)piperidine hydrochloride, 95.0%, 25g

(3S)-3-Amino-4,4,4-trifluoro-1-phenylbutan-1-one, 250mg

2-[(3-Fluorophenyl)methyl]isoindole-1,3-dione, 95%, 500mg

2,3,5,6-Tetrafluoro-4-methylbenzoic Acid>97.0%(GC)(T)1g

(2S,4R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 1g

6-[(2-Amino-1,3-benzothiazol-5-yl)methyl]-1,3-benzothiazol-2-amine, 90.0%, 250mg

4-Octyl Itaconate, 98.0%, 1g

2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid, 97.0%, 250mg

Vinyl Hexanoate (stabilized with MEHQ)>99.0%(GC)500mL

(R)-3-((tert-Butoxycarbonyl)amino)-3-(3-methoxyphenyl)propanoic acid, 95.0%, 1g

6,6-Dimethylpiperidine-2,4-dione, 95.0%, 100mg

4-Bromoquinoline-2-carboxylic acid, 95.0%, 100mg